Healthcare & Life Sciences

Karyopharm Therapeutics

Karyopharm Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 4 tracked investors.

Activeseries-c-plus

View Full Profile Website

series-c-plus

Stage

Investors

About Karyopharm Therapeutics

Based in the United States, Karyopharm Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.

Karyopharm Therapeutics is a commercial-stage pharmaceutical company focused on developing novel cancer therapies based on Selective Inhibitor of Nuclear Export (SINE) technology to target oncogenesis.

Explore Karyopharm Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

View Startup Profile →View pricing

Other Startups in United States

All startups →

Karyopharm Therapeuticsseries-c-plus Karusseries-b Karuna Health Karuna Therapeuticsseries-c-plus Kartos Therapeuticsseries-b Karoo Healthseed Karyosoft Kasaseries-c-plus Kasambaseed Kascaid Kaseyaseries-c-plus Kashableseries-c-plus